Goal

Alpha-MSH C-terminal tripeptide protocol for anti-inflammatory research.

Peptides

KPV

Why it works

KPV downregulates NF-kB signalling and pro-inflammatory cytokine production while lacking melanocortin-receptor pigmentary activity.

How to use

  • KPV — 200-500 mcg once or twice daily subcutaneous or orally.